Vitura Health Limited (ASX:VIT)
Australia · Delayed Price · Currency is AUD 0.0200
-0.0010 (-4.76%)
Sep 11, 2026, 10:22 AM AEST
Vitura Health Revenue
In the fiscal year ending June 30, 2026, Vitura Health had annual revenue of 131.16M AUD with 5.74% growth. Vitura Health had revenue of 63.29M in the half year ending June 30, 2026, a decrease of -0.95%.
Revenue
131.16M
Revenue Growth
+5.74%
P/S Ratio
0.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 131.16M | 7.12M | 5.74% |
| Jun 30, 2025 | 124.04M | 166.10K | 0.13% |
| Jun 30, 2024 | 123.87M | 6.53M | 5.56% |
| Jun 30, 2023 | 117.34M | 50.35M | 75.16% |
| Jun 30, 2022 | 66.99M | 45.28M | 208.54% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Little Green Pharma | 75.50M |
| Medical Developments International | 42.57M |
| ECS Botanics Holdings | 21.02M |
| IDT Australia | 20.38M |
| Epsilon Healthcare | 13.58M |
| Peak Processing | 12.51M |
| Cann Group | 9.65M |
| Syntara | 6.93M |